Web server

Rice’s web server helps identify COVID-19 drug

Image: Engineers at Rice University are leading the development of a web server to help researchers identify drugs to treat COVID-19. Their use of a set of conformations allows researchers to account for protein flexibility in molecular docking studies.
seen Following

Credit: Illustration by Mauricio Rigo / Rice University

HOUSTON – (November 1, 2021) – Researchers at Rice University have set up an online portal to help researchers screen for COVID-19 drug candidates that could attack specific proteins of the SARS-CoV-2 virus.

Lydia Kavraki, computer scientist at George R. Brown School of Engineering, and colleagues at the University of Houston, the University of Edinburgh, Scotland, and the Federal University of Ceará, Brazil, have uploaded a “user-friendly” web server that gives scientists the option to select virtually their drug candidates compared to known proteins. binding pockets on the SARS-CoV-2 virus.

Better yet, the program incorporates what they say is an often overlooked factor in the computer models of these pockets: their flexibility.

The project, detailed in an open access article in Computers in biology and medicine, incorporates models of three drug targets – the major protease (Mpro), RNA-dependent RNA polymerase (RdRp) and papain-like protease (PLpro) — for overall mooring through DINC-COVID.

The whole docking approach allows researchers to select candidates ligands (reactive molecules) against different conformations of SARS-CoV-2 proteins and their binding pockets. DINC-COVID then marks the successful binding of ligands.

DINC stands for “Docking INCrementally”, a protocol developed by the Kavraki laboratory in 2013 to speed up protein-peptide docking simulations that help researchers design drugs, vaccines, and other processes involving large ligands. a improved version led by Kavraki and Dinler Antunes, then a postdoctoral researcher in her lab and now an assistant professor at the University of Houston, appeared in 2017.

The new iteration is based on the “overwhelming number” of SARS-CoV-2 protein structures that have been resolved so far. Understanding these structures allows researchers to find binding partners that could, ideally, inactivate the virus.

The study also offers a literal twist, best represented by the main protease, a virus host site that has received a lot of attention over the past 18 months. The researchers found that the Mpro site can dramatically distort its shape in response to binding, allowing it to host a diverse set of potential ligands.

This malleability makes Mpro and other sites difficult to simulate, with a much higher computational cost, said Mauricio Rigo, postdoctoral researcher and co-author of Rice. “Unlike other servers, the proteins we provide are not static; they’re not a single conformation, ”he said. “We are using states to reflect the dynamics of this protein in a physiological environment.”

The team used several programs to reduce the sets of 100,000 possible conformations generated by a simulation of molecular dynamics, for example, to a set of representative conformations. This allows researchers to decouple generation of sets from docking in DINC-COVID, saving hours or days on complicated calculations.

“We think this was the right way to go,” Rigo said. “Our tests of the algorithm gave us a good match with the experimental results.”

With Mpro, the team modeled sets of catalytic binding sites on PLpro and RdRp. For Mpro, they modeled his catalytic and allosteric binding sites, for a total of 12 sets.

“We chose them because they can be targeted by different drugs,” said Sarah Hall-Swan, Rice graduate student and co-lead author of the article. “When you try to find a drug to inhibit a virus, you are going to look for the protein parts that are important for that virus to work and try to inhibit them.”

The lab is working to increase the number of sets available in DINC-COVID.

“We are very happy with the community response to our work,” Kavraki said. “DINC-COVID has already been used by around 500 researchers in 16 different countries, while our old DINC web server has been accessed by 11,000 users. We hope that DINC-COVID will help shed light on the complex mechanisms of SARS-CoV-2 infection. “

Didier Devaurs, former Rice postdoctoral researcher and now research fellow at the University of Edinburgh, is co-lead author of the article. Geancarlo Zanatta, associate professor of physics at the Federal University of Ceará, is a corresponding author. Kavraki is Professor of Computer Science Noah Harding, Professor of Bioengineering, Mechanical Engineering, and Electrical and Computer Engineering and Director of the Ken Kennedy Institute.

The National Science Foundation (2033262), the National Council for Scientific and Technological Development of Brazil (437373 / 2018-5), a scholarship from the University of Edinburgh and the Medical Research Council (MC_UU_00009 / 2), Cancer Prevention and Research Institute of Texas (RP170593), the National Institutes of Health (U01CA258512), and a National Library of Medicine Training Program Fellowship (T15LM007093-29) supported the research.

-30-

Read the summary on https://www.sciencedirect.com/science/article/pii/S001048252100737X#.

This press release can be viewed online at https://news.rice.edu/news/2021/rice-web-server-helps-identify-covid-19-drug-candidates.

Follow Rice News and Media Relations via Twitter @RiceUNews.

Associated materials:

Kavraki Laboratory: https://profiles.rice.edu/faculty/lydia-e-kavraki

Computer Science department : https://csweb.rice.edu

George R. Brown School of Engineering: https://engineering.rice.edu

Images to download:

https://news-network.rice.edu/news/files/2021/11/1101_COVID-1-WEB.jpg

Rice University engineers are leading the development of a web server to help researchers identify drugs to treat COVID-19. Their use of a set of conformations allows researchers to account for protein flexibility in molecular docking studies. (Credit: Illustration by Mauricio Rigo / Rice University)

https://news-network.rice.edu/news/files/2021/11/1101_COVID-5-WEB.jpg

A Rice University web server can help researchers identify potential drugs to treat COVID-19. In the physiological environment, a protein is not a static entity, but can move around and adopt a set of conformations. In this illustration, the main protease of SARS-CoV-2 is shown in green and several conformations are shown in light gray. (Credit: Illustration by Mauricio Rigo / Rice University)

Located on a 300-acre wooded campus in Houston, Rice University is consistently ranked among the top 20 universities in the country by US News & World Report. Rice has highly respected schools of architecture, business, continuing education, engineering, humanities, music, natural sciences, and social sciences and is home to the Baker Institute for Public Policy. With 4,052 undergraduates and 3,484 graduating students, Rice’s undergraduate student-to-faculty ratio is just under 6 to 1. Her residential college system builds close-knit communities and lasting friendships, one of the reasons Rice is ranked # 1 for many race / class interactions and # 1 for quality of life by the Princeton Review. Rice is also rated as the best value for money among private universities by Kiplinger’s Personal Finance.




Source link

Leave a Reply

Your email address will not be published. Required fields are marked *